Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 15633 | 631 | 49.0 | 92% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 532 | 14062 | TOLL LIKE RECEPTOR//TOLL LIKE RECEPTORS//CD14 |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | TOLL LIKE RECEPTOR 9 | Author keyword | 3 | 13% | 4% | 25 |
| 2 | TOLL LIKE RECEPTOR 3 | Author keyword | 2 | 11% | 3% | 17 |
| 3 | 95D CELL | Author keyword | 1 | 100% | 0% | 2 |
| 4 | DSRNA THERAPY | Author keyword | 1 | 100% | 0% | 2 |
| 5 | LD MCLEAN SURG S | Address | 1 | 50% | 0% | 2 |
| 6 | ORAL SQAUMOUS CELL CARCINOMA | Author keyword | 1 | 50% | 0% | 2 |
| 7 | POLY IC12U | Author keyword | 1 | 50% | 0% | 2 |
| 8 | MOL IMMUNOL PHARMACOL GRP | Address | 1 | 33% | 0% | 3 |
| 9 | OT 1 | Author keyword | 1 | 40% | 0% | 2 |
| 10 | SINGLE MOLECULE FORCE MEASUREMENT | Author keyword | 1 | 33% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | TOLL LIKE RECEPTOR 9 | 3 | 13% | 4% | 25 | Search TOLL+LIKE+RECEPTOR+9 | Search TOLL+LIKE+RECEPTOR+9 |
| 2 | TOLL LIKE RECEPTOR 3 | 2 | 11% | 3% | 17 | Search TOLL+LIKE+RECEPTOR+3 | Search TOLL+LIKE+RECEPTOR+3 |
| 3 | 95D CELL | 1 | 100% | 0% | 2 | Search 95D+CELL | Search 95D+CELL |
| 4 | DSRNA THERAPY | 1 | 100% | 0% | 2 | Search DSRNA+THERAPY | Search DSRNA+THERAPY |
| 5 | ORAL SQAUMOUS CELL CARCINOMA | 1 | 50% | 0% | 2 | Search ORAL+SQAUMOUS+CELL+CARCINOMA | Search ORAL+SQAUMOUS+CELL+CARCINOMA |
| 6 | POLY IC12U | 1 | 50% | 0% | 2 | Search POLY+IC12U | Search POLY+IC12U |
| 7 | OT 1 | 1 | 40% | 0% | 2 | Search OT+1 | Search OT+1 |
| 8 | SINGLE MOLECULE FORCE MEASUREMENT | 1 | 33% | 0% | 2 | Search SINGLE+MOLECULE+FORCE+MEASUREMENT | Search SINGLE+MOLECULE+FORCE+MEASUREMENT |
| 9 | 95D CELLS | 1 | 50% | 0% | 1 | Search 95D+CELLS | Search 95D+CELLS |
| 10 | CLASSICALLY ACTIVATED MACROPHAGE | 1 | 50% | 0% | 1 | Search CLASSICALLY+ACTIVATED+MACROPHAGE | Search CLASSICALLY+ACTIVATED+MACROPHAGE |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | EDGED SWORD | 11 | 78% | 1% | 7 |
| 2 | TLR2 ENGAGEMENT | 9 | 67% | 1% | 8 |
| 3 | TLR4 SIGNALING PROMOTES | 6 | 100% | 1% | 4 |
| 4 | INDUCED TUMOR GROWTH | 5 | 60% | 1% | 6 |
| 5 | NASOPHARYNGEAL CARCINOMA RISK | 5 | 60% | 1% | 6 |
| 6 | POLYCYTIDYLIC ACID CATIONIC LIPOSOME | 5 | 63% | 1% | 5 |
| 7 | PROMOTES TUMOR GROWTH | 5 | 19% | 4% | 23 |
| 8 | TLR3 | 4 | 18% | 3% | 21 |
| 9 | SYNTHETIC DSRNA | 3 | 100% | 0% | 3 |
| 10 | CELLULAR INVASION | 2 | 14% | 2% | 12 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| The Yin and Yang of Toll-like receptors in cancer | 2014 | 18 | 166 | 22% |
| Roles of toll-like receptors in Cancer: A double-edged sword for defense and offense | 2012 | 37 | 143 | 45% |
| Dual character of Toll-like receptor signaling: Pro-tumorigenic effects and anti-tumor functions | 2013 | 13 | 120 | 58% |
| TLR agonists: our best frenemy in cancer immunotherapy | 2013 | 15 | 186 | 33% |
| Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers | 2013 | 13 | 160 | 35% |
| The application of Toll like receptors for cancer therapy | 2010 | 30 | 49 | 45% |
| Toll-like receptors and cancer, particularly oral squamous cell carcinoma | 2014 | 3 | 75 | 39% |
| Toll-like receptors and cancer | 2009 | 258 | 149 | 13% |
| Toll-like receptor regulation of effector T lymphocyte function | 2013 | 21 | 108 | 21% |
| Trial Watch Toll-like receptor agonists for cancer therapy | 2013 | 26 | 226 | 17% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | LD MCLEAN SURG S | 1 | 50% | 0.3% | 2 |
| 2 | MOL IMMUNOL PHARMACOL GRP | 1 | 33% | 0.5% | 3 |
| 3 | AFFILIATED HOSP SOOCHOW 2 | 1 | 50% | 0.2% | 1 |
| 4 | BREAST SURG BREAST CANC | 1 | 50% | 0.2% | 1 |
| 5 | CANC US HLTH | 1 | 50% | 0.2% | 1 |
| 6 | COLORECTAL SURG SURGKAOHSIUNG MED | 1 | 50% | 0.2% | 1 |
| 7 | DENTWONKWANG BONE REGENERAT | 1 | 50% | 0.2% | 1 |
| 8 | DIRETTORE STRUTTURA COMPLESSA ANAT PATOL | 1 | 50% | 0.2% | 1 |
| 9 | FEDERATIF RECH 145 | 1 | 50% | 0.2% | 1 |
| 10 | GEN SURG MOL ONCOL IMMUNOTHER Y | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000213518 | CD14//CD14 POLYMORPHISM//TLR4 POLYMORPHISM |
| 2 | 0.0000176884 | INNATE IMMUNITY OF THE SKIN//PERMAFROST MICROORGANISMS//TYUMEN |
| 3 | 0.0000129787 | TIR DOMAIN//PELLINO//INNATE IMMUN INFLAMMAT |
| 4 | 0.0000129211 | POLY ICLC//AMPLIGEN//RAUSCHER MURINE LEUKEMIA VIRUS |
| 5 | 0.0000127819 | CPG ODN//CPG MOTIF//CPG DNA |
| 6 | 0.0000127585 | FLAGELLIN//TLR5//EPITHELIAL PATHOBIOL |
| 7 | 0.0000107802 | RIG I//IRF3//MDA5 |
| 8 | 0.0000104490 | UNC93B1//MARY KIRKLAND LUPUS//TLR7 |
| 9 | 0.0000086758 | RENAL MED TRANSPLANT GRP//RD DISCOVERY//UNSTABLE CAROTID PLAQUE |
| 10 | 0.0000072624 | MD 2//CD14//LIPOPOLYSACCHARIDE BINDING PROTEIN |